Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 44749

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2024 | Month : April | Volume : 18 | Issue : 4 | Page : PC04 - PC09 Full Version

Comparison of Clinicopathological Characteristics of Patients with Early and Late-onset Colorectal Adenocarcinoma: A Cross-sectional Study


Published: April 1, 2024 | DOI: https://doi.org/10.7860/JCDR/2024/66422.19262
Bodhisattva Bose, Sunil Kumar Singh, H Sunil, Amit Gupta, Deepak Sundriyal, Rajkumar Kottayasamy Seenivasagam, Itish Patnaik, Deepa Joseph

1. Resident, Department of Surgical Oncology, AIIMS, Rishikesh, Uttarakhand, India. 2. Resident, Department of Surgical Oncology, AIIMS, Rishikesh, Uttarakhand, India. 3. Resident, Department of Surgical Oncology, AIIMS, Rishikesh, Uttarakhand, India. 4. Professor, Department of Surgery, AIIMS, Rishikesh, Uttarakhand, India. 5. Assistant Professor, Department of Medical Oncology, AIIMS, Rishikesh, Uttarakhand, India. 6. Professor, Department of Surgical Oncology, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India. 7. Assistant Professor, Department of Gastromedicine, AIIMS, Rishikesh, Uttarakhand, India. 8. Additional Professor, Department of Radiation Oncology, AIIMS, Rishikesh, Uttarakhand, India.

Correspondence Address :
Dr. Amit Gupta,
Professor, Department of Surgery, AIIMS, Rishikesh-249203, Uttarakhand, India.
E-mail: dramit2411@gmail.com

Abstract

Introduction: Colorectal Cancer (CRC) has been primarily considered a disease of the elderly, but recent data have shown an alarming rise among young people. It has also been suggested that young age is associated with aggressive histopathological characteristics and advanced stages of the disease at diagnosis.

Aim: To assess and compare the clinical and pathological characteristics of patients with rectal cancer diagnosed at ages over and below 45 years.

Materials and Methods: This prospective cross-sectional study was conducted between January 2020 and August 2022 in the Departments of Surgical, Medical, Radiation Oncology, Surgical Gastroenterology, and General Surgery at All India Institute of Medical Sciences (AIIMS) Rishikesh, Uttarakand, India. All patients underwent a biopsy from the representative site for histological documentation of the disease. They then underwent treatment (surgery/chemotherapy/radiotherapy) as required. All the data were categorised into two groups: an early-onset group (age <45 years) and a late-onset group (≥45 years). A comparison of the clinicopathological characteristics (age, gender, co-morbidities, tumour subsite, clinical presentation, clinical stage, etc.), pathological data (grade and differentiation of tumour, as per World Health Organisation (WHO) grading system), and serum Carcinoembryonic Antigen (CEA) levels between the two groups was performed. The association between categorical variables was investigated using the Chi-square test. The mean difference was assessed using an independent t-test. A p-value of 0.05 or below was considered statistically significant.

Results: A total of 51 patients with rectal cancer, 35 males and 16 females, were included in the study. The mean age was 44.73±16.47 years. Out of the total of 51 (100%) patients, lower rectum involvement was seen in 22 (43.1%) patients, followed by 7 (13.7%) patients each with ascending colon and sigmoid involvement resepectively. However, the Chi-square test showed no statistically significant association of location involved with age groups (χ2=9.09; p=0.16). Out of 51 (100%) adenocarcinoma patients in total, three patients each under 45 years of age had signet cell adenocarcinoma and mucinous adenocarcinoma (χ2=7.07; p=0.029). Among the total of 51 (100%) patients, moderately differentiated lesions were seen in 17 (33.3%) patients, poorly differentiated lesions were seen in 15 (29.4%) patients, and well-differentiated lesions were seen in 10 (19.6%) patients (χ2=13.01; p=0.005).

Conclusion: Younger patients tended to have larger tumours that were of a higher grade and had signet ring or mucinous histopathology. The social and clinical implications of these findings are to be explored.

Keywords

Age, Colorectal cancer, Signet cell, Treatment, Tumour

Colorectal Cancer (CRC) is the third most common cancer in the world (1). It is the most common gastrointestinal tract malignancy and the third leading cause of cancer-related death globally (2). While CRC typically affects elderly patients, current research indicates a rising incidence of CRC in individuals under 45 years of age (3).

In developed nations, it is hypothesised that improved screening procedures and greater awareness have led to higher detection rates among younger individuals. In developing nations, there may be an association between these trends and changes in dietary patterns and westernised food habits, leading to an increase in obesity among younger generations. Whether CRC in young people has distinct biology or if clinical expression and treatment response differ from late-onset CRC remains unknown, with previous studies yielding conflicting results (4).

Most studies on sporadic early-onset CRC have focused on Western populations. There is a lack of studies on the clinicopathological presentation of sporadic early-onset CRC from India. The findings of present study indicate a significant proportion of early-onset CRC cases among Indian patients (4). The present research is crucial for understanding the pathological and clinical presentation of early-onset CRC and determining if they differ from late-onset tumours. The study hypothesised that patients with early-onset CRCs exhibit different clinical and pathological characteristics compared to those with late-onset CRC. There are few studies, evaluating the clinicopathological profile of early-onset versus late onset rectal cancer patients. The study was conducted to assess and compare the clinical and pathological characteristics of patients diagnosed with rectal cancer at ages over and under 45 years.

Material and Methods

This prospective cross-sectional study was conducted from January 2020 to August 2022, and included 51 CRC patients from the Departments of Surgical, Medical and Radiation Oncology at All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India. Prior to commencing the study, Institutional Ethical Committee (IEC) approval was obtained vide letter no. (50/IEC/PGM/2021). Given the time constraints and exploratory nature of the study, a convenient sampling method was utilised. The aim was to collect data from a minimum of 25 patients with early-onset CRC. As there is no universal definition for “early onset” CRCs, 45 years of age was taken as the cut-off in the present study, which is close to median age of 47 years in our country. With the median age of CRC presentation in India being around 45 years, it was estimated that 50 patients would be needed to meet this target.

Inclusion and Exclusion criteria: Comprised biopsy-proven colorectal adenocarcinoma, individuals aged ≤80 years, and those willing to participate in the research (with written informed consent). Exclusion criteria included individuals unable or unwilling to provide consent, as well as patients with a personal or family history of CRC.

Study Procedure

The research was entirely observational and had no bearing on the clinical care provided to patients during their treatment. All clinical decisions were made by the treating professionals overseeing the patients.

Patients underwent proper staging, clinical evaluations, and other necessary examinations. Staging was done according to American Joint Committee on Cancer (AJCC) 8th edition (5). Subsequently, patients received treatment (surgery/chemotherapy/radiotherapy) and other necessary therapy as per multidisciplinary tumour board guidelines and decisions (Table/Fig 1).

Data collected included epidemiological information (age, gender, co-morbidities and assessment according to Charlson co-morbidity index (6), and demographic profile), clinical data (tumour subsite, clinical presentation, clinical stage, etc.), pathological data (tumour grade and differentiation as per the WHO grading system), and serum CEA levels at presentation (following diagnosis confirmation).

Statistical Anlaysis

The windows version of IBM Statistical Package for Social Sciences (SPSS) version 23.0 was employed for data analysis. Categorical variables were presented as proportions, while continuous variables were expressed as mean±Standard Deviation (SD) or median±interquartile range, depending on their distribution. The association between categorical variables was analysed using the Chi-square test, and the mean difference was evaluated using an independent t-test. A p-value of 0.05 or below was considered statistically significant.

Results

The mean age of the patients was 44.73±16.47 years. The proportion of males in the early onset cohort was proportionately higher than in the late onset cohort: 19 (76%) versus (vs) 16 (61.5%) male patients, respectively. However, no statistically significant link between gender and age groups was discovered when the Chi-square test was used to examine this relationship (χ2=1.23; p=0.26). In the present study, alcohol was consumed by 10 (19.6%) patients in total, out of which 8 (30.8%) patients were aged ≥45 years. Tobacco was consumed by seven patients in each group. A Chi-square test revealed a statistically significant association between age groups and alcohol drinking habits (χ2=4.19; p=0.041). Contrarily, there was no significant relationship between tobacco use and age groups (χ2=0.007; p=0.93) (Table/Fig 2) (6).

Out of the total of 51 (100%) patients, lower rectum involvement was seen in 22 (43.1%) patients followed by 7 (13.7%) patients each with ascending colon and sigmoid involvement. However, the Chi-square test showed no statistically significant association of the location involved with age groups (χ2=9.09; p=0.16) (Table/Fig 3).

The mode of presentation was elective among 42 (82.4%) patients, out of which 19 (76%) patients were aged <45 years, and 23 (88.5%) patients were aged ≥45 years. An emergency mode of presentation was seen in 9 (17.6%) patients. The Chi-square test showed no statistically significant association of the mode of presentation with age groups (χ2=1.36; p=0.24). Serum CEA levels were raised in patients under 45 years but were statistically insignificant (p=0.33) (Table/Fig 4).

Radiological features: Among a total of 51 (100%) patients, obstruction was not seen in any patients, perforation was present in 1 (2%) subject, and breach in the peritoneum was seen in 26 (51%) patients. However, the Chi-square test showed no statistically significant association with obstruction, perforation (p=0.32), breach in the peritoneum (p=0.88), invasion to surrounding structures (p=0.61), lymph node involvement (p=0.406), and metastasis (p=0.35) (Table/Fig 5).

Mean scores of the quantitative parameters were compared between the groups (<45 years and >45 years) using an independent sample t-test. The mean length (cm) of the tumour was found to be higher in patients aged <45 years, i.e., 6.87±2.33 compared to patients aged ≥45 years with 5.25±1.82. The independent sample t-test showed a statistically significant difference between the groups and the tumour length of patients (p=0.016) with a mean difference of 1.62.

In the present study, out of 51 (100%) adenocarcinoma patients in total, three patients each of <45 years had adenocarcinoma (Signet cell) and mucinous adenocarcinoma. The Chi-square test showed a statistically significant association of histological type with age groups (χ2=7.07; p=0.029) (Table/Fig 6). Among a total of 51 (100%) patients, moderately differentiated lesions were seen in 17 (33.3%) patients, poorly differentiated lesions were seen in 15 (29.4%) patients, and well-differentiated lesions were seen in 10 (19.6%) patients. The Chi-square test showed a statistically significant association of types of lesion differentiation with age groups (χ2=13.01; p=0.005) (Table/Fig 7).

Discussion

One of the leading causes of morbidity and mortality in the world is CRC, with varied incidence as well as clinical presentation across different geographical regions. The present research evaluated the clinicopathological characteristics of patients with CRC centred on their age. Generally, CRC has long been believed to be a disease of the elderly (1). Nevertheless, in present study, the mean age was 30 years in the group <45 years of age and 58 years in the group ≥45 years, although the mean age of the groups taken together was 44.73 years. The majority of patients were from Uttar Pradesh-27 (52.9%), followed by 22 (43.1%) of the patients from Uttarakhand. 1 (2%) subject each was from Delhi and Haryana. According to some recent research, CRC is becoming more common among young people in the Middle East and other parts of the world (2). In the United States of America (USA), there is an increased incidence of CRC in people below 50 years, as shown by Kasi PM et al., 2019 (3). Research conducted on 233 patients in Central India over eight years revealed that the median age at diagnosis was 43 years (7). The mean age of patients with CRC was observed to be 47.01 years in another study from Eastern India (8). Patil PS et al., conducted a single-centre-based audit on CRC in India and opined that it is different compared to Western countries, with a greater number of young patients in India (9). Many studies showed that young patients with CRC are more likely to have poor histological features and are often presented in an advanced stage compared to the older age group (10). These findings suggest that young patients with CRC could be a distinct biological entity and require more intensive treatment (11). The impact of age on the presentation and survival of CRC patients, however, remains controversial.

The present study population showed that patients aged <45 years and ≥45 years were predominantly males compared to females. This aligns with current studies demonstrating that men experience a higher incidence of CRC than women (12),(13). The incidence rate ratio of male-to-female gradually rises from the caecum to the rectum, from almost one for caecal cancers to two for rectal cancers (13). Although the cause of CRC has not been fully understood, Murphy G et al., opined that differential exposure to risk factors associated with diet and lifestyle, such as alcohol and red meat consumption, as well as differences in hormone and other receptor expressions along the length of the colon and rectum, may be the most common culprits (14).

Authors did not find a significant difference between the early-onset and late-onset groups in terms of socioeconomic status and educational status. These findings in present study are in agreement with the study results of Thomas R et al., (15).

Co-morbidities are substantially more common in patients with late-onset CRC than in those with early-onset CRC. The present study supports a study that examined the connection between diabetes and CRC (16).

In present study, rectal bleeding and abdominal pain were the most frequently reported symptoms in both age groups. These findings are in accordance with the published literature (17). Low EE et al., observed that weight loss is an important early clinical sign that may be linked to early-onset CRC (18).

Numerous observational studies report the association of smoking as well as alcoholism with early-onset CRC (18),(19),(20). In present study, alcohol was consumed by 10 (19.6%) patients in total, out of which 8 (30.8%) patients were aged ≥45 years, showing a statistically significant association of alcohol consumption habits with age groups. Tobacco was consumed by seven patients in both groups. Thomas R et al., found no substantial difference in the frequency of either drinking or smoking tobacco between patients with early-onset and late-onset CRC (15).

Abdominal Computed Tomography (CT) frequently reveals Colonic Wall Thickening (CWT), a radiologic abnormality (16),(17),(18),(19). It may be connected to benign or non pathological illnesses, but in many instances, it can be a marker of serious pathologies such as neoplastic and Inflammatory Bowel Disease (IBD) (20),(21). Previous research has indicated that patients with CWT had a 7-21% malignancy rate (22),(23). In present study, among 51 (100%) patients, thickening was seen in 45 (88.2%) patients with almost equal distribution in both age groups. In a recent study, localised CWT was found to be independently linked with CRC, whereas a higher platelet count and younger age were separately linked with IBD (24).

In present study population, out of 51 (100%) patients, lower rectum involvement was seen in 22 (43.1%) patients, followed by 7 (13.7%) patients each with ascending colon and sigmoid involvement. According to Patil PS et al., anorectal/rectal disease impacted around 54% of the patients in India (9). Laskar RS et al., also found that low rectal tumours predominated in Northeast Indian patients, which is similar to our study (25).

Trivedi V et al., observed that younger individuals were more likely to have intestinal obstruction and perforation compared to faecal incontinence, which is more persistent in older patients (26). Additionally, younger age groups reported intestinal perforations, obstruction, as well as colostomy more frequently. This might be due to the disease’s more aggressive nature in younger patients or due to the longer duration of symptoms (8).

Colon wall thickening was observed in the cecum, descending colon, transverse colon, ascending colon, sigmoid colon, and rectum, among other areas of the colon. CWT that is only found in one of the colon’s aforementioned regions, regardless of its length, such as solely in the ascending colon, is referred to as localised thickening (24). In present study, among 51 (100%) patients, lower rectum involvement was observed in 22 (43.1%) patients, followed by 7 (13.7%) patients each with involvement in the ascending colon and sigmoid colon. Consistent with present study findings, Trivedi V et al., reported that rectum involvement was present in 70 (31.25%) patients and in 25 (11.16%) patients, the sigmoid colon was involved in rectal cancer (26). Saluja SS et al., evaluated 112 patients under 45 years of age and found that individuals with a family history of CRC often had tumours localised in the proximal colon, while 77% of patients without a family history of CRC had tumours in the distal colo-rectum (27). According to Chang DT et al., CRCs found in patients under the age of 40 have a preference for the distal colon (80%), specifically the sigmoid colon (44%) and rectum (36%) (28).

The incidence as well as mortality of CRC are significantly reduced by colonoscopy-based early diagnosis and excision of these precancerous lesions (29). CRC has been viewed as largely a disease of the elderly, typically developing during the fifth decade of life (30). As a result, screening for CRC has been recommended for people aged 50 to 75 years by numerous advisory committees worldwide (31). However, recent data from Western and Asian countries have revealed an increase in the incidence of CRC among patients under 50 years of age. Consequently, the United States (US) Preventive Services Task Force modified its recommendations for colon cancer screening age range, stating that it should start at 45 years of age rather than 50 years (32). Additionally, studies have shown that younger age groups upon diagnosis are associated with significantly more advanced disease stages and more aggressive histological characteristics that negatively impact survival (33).

Out of the 51 (100%) patients with adenocarcinoma, 25 patients were aged <45 years, and 26 patients were aged ≥45 years. Three patients in each age group had adenocarcinoma (Signet cell) and mucinous adenocarcinoma, which is significant. The present finding is similar to the study by Thomas R et al., which found that adenocarcinoma was higher in late-onset age groups compared to early-onset age groups (15). In the research conducted by Trivedi V et al., adenocarcinoma was the most common histology seen in both age groups. Young patients showed a higher incidence of adenocarcinoma with signet cell carcinoma as well as a signet ring component, which was 4.05% and 8.78%, respectively, compared to 1.31% and 39.4% in the older group, respectively (26). Additionally, 6.08 percent of young patients were found to have adenocarcinoma with a mucinous component, compared to 3.94 percent of individuals in the elderly group (25).

Limitation(s)

A prolonged period of participant accrual was experienced due to the ongoing COVID-19 pandemic and there is a lack of adequate follow-up data.

Conclusion

Younger patients tended to have larger tumours that were of a higher grade and had signet ring or mucinous histopathology. The social and clinical implications of these findings are to be explored.

References

1.
Siegel RL, Miller KD, Jemal A. Cancerstatistics, 2018. CA Cancer J Clin. 2018;68(1):07-30. [crossref][PubMed]
2.
You YN. Young-onset colorectal cancer: Is it time to pay attention? Arch Intern Med. 2012;172(3):287. [crossref][PubMed]
3.
Kasi PM, Shahjehan F, Cochuyt JJ, Li Z, Colibaseanu DT, Merchea A. Rising proportion of young individuals with rectal and colon cancer. Clin Colorectal Cancer. 201;18(1):e87-95. [crossref][PubMed]
4.
Pokharkar AB, Bhandare M, Patil P, Mehta S, Engineer R, Saklani AP. Young vs old colorectal cancer in indian subcontinent: A tertiary care center experience. Indian J Surg Oncol. 2017;8(4):491-98. Doi: 10.1007/s13193-017-0670-1. Epub 2017 May 26. PMID: 29203979; PMCID: PMC5705508. [crossref][PubMed]
5.
Weiser MR. AJCC 8th edition: Colorectal Cancer. Ann Surg Onco. 2018;25:1454-55. [crossref][PubMed]
6.
Glasheen WP, Cordier T, Gumpina R, Haugh G, Davis J, Renda A. Charlson comorbidity index: ICD-9 Update and ICD-10 Translation. Am Health Drug Benefits. 2019;12(4):188-97.
7.
Hussain N, Gahine R, Mourya J, Sudarshan V. Colorectal cancer in young adults in a tertiary care hospital in Chhattisgarh, Raipur. Indian J Cancer. 2013;50(4):337. [crossref][PubMed]
8.
Sarkar S, Mukherjee R, Paira SK, Roy B, Banerjee S, Mukherjee SK. Profile of colorectal cancer in Eastern India. J Indian Med Assoc. 2012;110(12):901-03.
9.
Patil PS, Saklani A, Gambhire P, Mehta S, Engineer R, De’Souza A, et al. Colorectal Cancer in India: An Audit from a tertiary center in a low prevalence area. Indian J Surg Oncol. 2017;8(4):484-90. [crossref][PubMed]
10.
McMillan DC, McArdle CS. The impact of young age on cancer-specific and non-cancer-related survival after surgery for colorectal cancer: 10-year follow-up. Br J Cancer. 2009;101(4):557-60. [crossref][PubMed]
11.
Connell LC, Mota JM, Braghiroli MI, Hoff PM. The rising incidence of younger patients with colorectal cancer: Questions about screening, biology, and treatment. Curr Treat Options Oncol. 2014;18(4):23. [crossref][PubMed]
12.
Patra T, Mandal S, Alam N, Murmu N. Clinicopathological trends of colorectal carcinoma patients in a tertiary cancer centre in Eastern India. Clinical Epidemiol Glob Health. 2018;6(1):39-43. [crossref]
13.
Perdue DG, Perkins C, Jacksonompson J, Coughlin SS, Ahmed F, Haverkamp DS, et al. Regional differences in colorectal cancer incidence, stage, and subsite among American Indians and Alaska Natives, 1999-2004. Cancer. 2008;113(5Suppl):1179-90. [crossref][PubMed]
14.
Murphy G, Devesa SS, Cross AJ, Inskip PD, McGlynn KA, Cook MB. Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int J Cancer. 2011;128(7):1668-75. [crossref][PubMed]
15.
Chimmen JV, Thomas R, Jose P, Joseph L. A comparative study on the clinico-pathological characteristics of early versus late onset colorectal carcinoma cases in a tertiary care centre in central Kerala. IJPO. 2020;7(1):99-103. [crossref]
16.
Starup-Linde J, Karlstad O, Eriksen SA, Vestergaard P, Bronsveld HK, de Vries F, et al. CARING (CAncer Risk and INsulin analoGues): The association of diabetes mellitus and cancer risk with focus on possible determinants-A systematic review and a meta-analysis. Curr Drug Saf. 2013;8(5):296-332. Doi: 10.2174/15748863113086660071. PMID: 24215312; PMCID: PMC5421136. [crossref][PubMed]
17.
Astin M, Griffin T, Neal RD, Rose P, Hamilton W. The diagnostic value of symptoms for colorectal cancer in primary care: A systematic review. Br J Gen Pract. 2011;61(586):e231-43. [crossref][PubMed]
18.
Low EE, Demb J, Liu L, Earles A, Bustamante R, Williams CD, et al. Risk factors for early-onset colorectal cancer. Gastroenterology. 2020;159(2):492-501.e7. [crossref][PubMed]
19.
Boutron MC, Faivre J, Dop MC, Quipourt V, Senesse P. Tobacco, alcohol, and colorectal tumors: A multi step process. Am J Epidemiol. 1995;141(11):1038-46.
20.
Zisman AL, Nickolov A, Brand RE, Gorchow A, Roy HK. Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: Implications for screening. Arch Intern Med. 2006;166(6):629. [crossref][PubMed]
21.
Buc E, Kwiatkowski F, Alves A, Panis Y, Mantion G, Slim K. Tobacco smoking: A factor of early onset of colorectal cancer. Dis Colon Rectum. 2006;49(12):1893-96. [crossref][PubMed]
22.
Moraitis D, Singh P, Jayadevan R, Cayten CG. Colonic wall thickening on computed tomography scan and clinical correlation. Does it suggest the presence of an underlying neoplasia? Am Surg. 2006;72(3):269-71. [crossref][PubMed]
23.
Wolff JH, Rubin A, Potter JD, Lattimore W, Resnick MB, Murphy BL, et al. Clinical significance of colonoscopic findings associated with colonic thickening on computed tomography: Is colonoscopy warranted when thickening is detected? J Clin Gastroenterol. 2008;42(5):472-75. [crossref][PubMed]
24.
Pothoulakis I, Wikholm C, Verma V, Ahmad AI, Vangimalla SS, Patel H, et al. Predictors of colorectal carcinoma and inflammatory bowel disease in patients with colonic wall thickening. JGH Open. 2022;6(3):159-65. [crossref][PubMed]
25.
Laskar RS, Talukdar FR, Mondal R, Kannan R, Ghosh SK. High frequency of young age rectal cancer in a tertiary care centre of southern Assam, North East India. Indian J Med Res. 2014;139(2):314-18.
26.
Trivedi V, Chauhan R, Subham S, Rani R, Singh U. A comparative analysis of the clinicopathological profile of early-onset versus late-onset rectal cancer patients. E cancer medical science. 2022;16:1365. [crossref][PubMed]
27.
Saluja SS, Manipadam JM, Mishra PK, Sachdeva S, Solanki N, Shah H. Young onset colorectal cancer: How does it differ from its older counterpart? Indian J Cancer. 2014;51(4):565. [crossref][PubMed]
28.
Chang DT, Pai RK, Rybicki LA, Dimaio MA, Limaye M, Jayachandran P, et al. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: An adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic feature. Mod Pathol. 2012;25(8):1128-39. [crossref][PubMed]
29.
Zauber AG, Winawer SJ, O’Brien MJ, Lansdorp-Vogelaar I, vanBallegooijen M, Hankey BF, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687-96. [crossref][PubMed]
30.
Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89-103. [crossref][PubMed]
31.
Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A, ESMO Guidelines Working Group. Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 2010;21(Suppl5):v70-77.[crossref][PubMed]
32.
Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS, et al. Changes in colorectal cancer incidence in seven high-income countries: A population-based study. Lancet Gastroenterol Hepatol. 2019;4(7):511-18. [crossref][PubMed]
33.
Zhao L, Bao F, Yan J, Liu H, Li T, Chen H, et al. Poor prognosis of young patients with colorectal cancer: A retrospective study. Int J Colorectal Dis. 2017;32(8):1147-56.[crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2024/66422.19262

Date of Submission: Jul 07, 2023
Date of Peer Review: Sep 07, 2023
Date of Acceptance: Feb 02, 2024
Date of Publishing: Apr 01, 2024

Author declaration:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jul 12, 2023
• Manual Googling: Sep 09, 2023
• iThenticate Software: Jan 30, 2024 (15%)

Etymology: Author Origin

Emendations: 9

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com